Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
A common condition that contributes to Chronic Obstructive Pulmonary Disease (COPD) is emphysema, which involves damage to the walls of air sacs in the lung. There are very limited safe and non-invasive options available, therefore IKOMED Technologies Inc. has been developing an application using radiofrequency wave technology that has shown the potential to non-surgically improve disease burden. The initial study was performed in the rodent model of emphysema with Dr. Don Sin, and study in larger animals is important for translation to clinical use. The intern will work within a multi-disciplinary team to develop a model of emphysema in pigs, and then evaluate the safety of exposure to energy from radiofrequency waves, and its effectiveness in the treatment of emphysema. IKOMED Technologies Inc. is the sponsor of this work and will be acknowledged in potential publications. The data collected may be used for future patenting of this new treatment technology.
Don Sin
IKOMED Technologies Inc
Life Sciences
Professional, scientific and technical services
The University of British Columbia
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.